WAT Waters Corporation

Waters Corporation Elects Flemming Ornskov to Board of Directors

Waters Corporation (NYSE: WAT) today announced Dr. Flemming Ornskov, Chief Executive Officer of Shire plc, has been elected as a Director of Waters® Corporation effective today.

"It is an honor to welcome Flemming Ornskov to our Board of Directors," said Christopher J. O'Connell, Waters Corporation President and CEO. "Flemming's broad, global leadership experience in the biopharmaceutical industry will add great value to Waters' strategic and governance processes. Moreover, Flemming's strong character and passion for human health make him a great addition to Waters' values-oriented culture."

“I have been impressed with the Waters Corporation’s support for researchers and organizations whose innovative work helps heal, feed and protect people around the world,” said Shire’s Flemming Ornskov, M.D., M.P.H. “I look forward to working with Chris and the entire Board in pursuing a bright future for the Company, its employees and those they serve.”

Dr. Ornskov was appointed Chief Executive Officer of Shire plc in April, 2013, where he serves as Chairman of the Executive Committee, and is a member of the Board of Directors. Dr. Ornskov brings broad operational and medical knowledge, and extensive international, strategic and operational experience in the pharmaceutical sector. Prior to Shire, Dr. Ornskov held key executive leadership positions at Bayer, Bausch & Lomb, Inc., Merck & Co., Inc. and Novartis AG. Dr. Ornskov received his MD from the University of Copenhagen, his MBA from INSEAD, and his Master of Public Health from Harvard University. Before his business career, Dr. Ornskov, trained as an intern and resident in pediatrics at the University Hospital of Copenhagen.

About Waters Corporation (www.waters.com)

Waters Corporation (NYSE: WAT), the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry and thermal analysis innovations serving the life, materials and food sciences for nearly 60 years. With approximately 7,000 employees worldwide, Waters operates directly in 27 countries, including 11 manufacturing facilities, and with products available in more than 100 countries.

Waters is a registered trademark of the Waters Corporation.

EN
22/06/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Waters Corporation

Waters Corp: 1 director

A director at Waters Corp bought 1,000 shares at 332.900USD and the significance rating of the trade was 87/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

 PRESS RELEASE

Waters Launches its Most Sensitive and Compact Clinical IVD System wit...

MONTEREY, Calif.--(BUSINESS WIRE)-- MSACL Conference 2023--Waters Corporation (NYSE:WAT) today unveiled its next generation Xevo TQ Absolute IVD mass spectrometer, expanding its family of for clinical diagnostic applications. This press release features multimedia. View the full release here: Waters' newest MassTrak IVD LC-MS/MS System featuring the Xevo TQ Absolute IVD tandem quadrupole mass spectrometer (in dark grey), is up to five times more sensitive than similar commercial mass spectrometers for quantifying analytes in samples of saliva, breath, and dried blood spots. (Photo: Business...

 PRESS RELEASE

Waters Corporation Appoints Richard Fearon to Board of Directors

MILFORD, Mass.--(BUSINESS WIRE)-- Waters™ Corporation (NYSE:WAT) today announced the appointment of Richard Fearon to its Board of Directors, effective March 27, 2023. Mr. Fearon is the former Vice Chairman and Chief Financial and Planning Officer of Eaton Corporation, a multinational power management company. “Rick’s expertise is at the intersection of financial excellence, strategic development and transformation, which are the key pillars of Waters’ growth plan. We are confident that Rick’s unique skillset will complement our Board well and we look forward to benefiting from his insights a...

 PRESS RELEASE

Waters lance le système de CLHP Alliance iS de nouvelle génération, qu...

PHILADELPHIE--(BUSINESS WIRE)-- PITTCON 2023 – Waters Corporation (NYSE:WAT) a lancé aujourd'hui , le système intelligent de CLHP de nouvelle génération, conçu pour réduire le risque de conformité en ajoutant de nouveaux niveaux de détection proactive des erreurs, de résolution des problèmes et une facilité d’utilisation. Lorsqu’il est associé au conforme et à de Waters, le système de chromatographie liquide à haute performance (CLHP) Alliance iS permet de rationaliser la tâche consistant à faire des mesures exactes et précises en détectant et éliminant les erreurs courantes jusqu’à 40 %.i C...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch